Titlebook: Current Research and Clinical Management of Melanoma; Larry Nathanson Book 1993 Kluwer Academic Publishers 1993 Staging.cell.genetics.immu

memoir

書目名稱Current Research and Clinical Management of Melanoma影響因子(影響力)




書目名稱Current Research and Clinical Management of Melanoma影響因子(影響力)學(xué)科排名




書目名稱Current Research and Clinical Management of Melanoma網(wǎng)絡(luò)公開度




書目名稱Current Research and Clinical Management of Melanoma網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Current Research and Clinical Management of Melanoma被引頻次




書目名稱Current Research and Clinical Management of Melanoma被引頻次學(xué)科排名




書目名稱Current Research and Clinical Management of Melanoma年度引用




書目名稱Current Research and Clinical Management of Melanoma年度引用學(xué)科排名




書目名稱Current Research and Clinical Management of Melanoma讀者反饋




書目名稱Current Research and Clinical Management of Melanoma讀者反饋學(xué)科排名

過分

Fulminate

歡樂東方

https://doi.org/10.1007/978-3-642-57192-3 primary tumor allows confirmation that the tumor is melanocyte derived, that it is malignant and primary in the site, provides indications of the likelihood that it will metastasize, and confirms the completeness of excision. Evaluation of tissues from sites that, on clinical grounds, are regarded

某人

https://doi.org/10.1007/978-3-642-57192-3 social, and economic morbidity consequent upon the natural history of neoplastic disease and its treatment (even when successful) is truly enormous. The ability to prevent a given disease has typically lagged far behind our ability to treat that disease. Historically, physicians have been accustome

defile

https://doi.org/10.1007/978-3-642-57192-3ry intraocular malignancy, with a high incidence of tumorrelated deaths [.,.]. Numerous unanswered questions regarding the etiology, natural history, and appropriate management of this disease continue to stimulate both vivid controversy and active research in ophthalmic oncology. In this chapter we

defile

Mechanics

健談的人

排斥

https://doi.org/10.1007/978-3-642-57192-3 between 1973 and 1987. If this trend continues, it is estimated that the lifetime risk of developing melanoma for someone born in 1950, 1:600, will increase to 1:90 for someone born in the year 2000. Fortunately, of the 32,000 new cases diagnosed in the United States in 1992, the vast majority will